Jordan vs Landlocked developing countries (LLDCs): Percentage of bloodstream infection due to methicillin-resistant
Jordan
76.3%
in 2022
Landlocked developing countries (LLDCs)
53.8%
in 2022
Jordan rank
1st
Landlocked developing countries (LLDCs) rank
3rd
Percentage of bloodstream infection due to methicillin-resistant over time
- Jordan
- Landlocked developing countries (LLDCs)
How they compare
Jordan currently reports 76.3% against 53.8% in Landlocked developing countries (LLDCs), a difference of 22.5%.
That makes Jordan's figure about 1.4 times Landlocked developing countries (LLDCs)'s.
The two have swapped places 2 times across 5 shared years of data; in 2018 it was Jordan ahead.
Jordan ranks 1st and Landlocked developing countries (LLDCs) ranks 3rd of 44 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jordan | Landlocked developing countries (LLDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 60.1% | 21.0% | 39.1% | Jordan |
| 2020s | 68.5% | 62.2% | 6.2% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Jordan or Landlocked developing countries (LLDCs)?
- Jordan, at 76.3% against 53.8% in Landlocked developing countries (LLDCs) as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Jordan and Landlocked developing countries (LLDCs)?
- 22.5%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Landlocked developing countries (LLDCs)?
- 5 years are reported by both, from 2018 to 2022.
- How do Jordan and Landlocked developing countries (LLDCs) rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Jordan ranks 1st and Landlocked developing countries (LLDCs) ranks 3rd of 44 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.